BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 30782501)

  • 41. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Jat KR; Walia DK; Khairwa A
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010288. PubMed ID: 29551015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Elphick HE; Southern KW
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD002204. PubMed ID: 27820955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
    Periselneris J; Nwankwo L; Schelenz S; Shah A; Armstrong-James D
    J Antimicrob Chemother; 2019 Jun; 74(6):1701-1703. PubMed ID: 30805605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allergic bronchopulmonary aspergillosis in children.
    Manti S; Parisi GF; Papale M; Licari A; Chiappini E; Mulè E; Rotolo N; Leonardi S
    Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26():20-22. PubMed ID: 33236425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Azoles for allergic bronchopulmonary aspergillosis associated with asthma.
    Wark P; Wilson AW; Gibson PG
    Cochrane Database Syst Rev; 2001; (4):CD001108. PubMed ID: 11687098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of allergic bronchopulmonary aspergillosis: from evidence to practice.
    Dhooria S; Sehgal IS; Muthu V; Agarwal R
    Future Microbiol; 2020 Mar; 15():365-376. PubMed ID: 32286102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.
    Perisson C; Destruys L; Grenet D; Bassinet L; Derelle J; Sermet-Gaudelus I; Thumerelle C; Prevotat A; Rosner V; Clement A; Corvol H
    Respir Med; 2017 Dec; 133():12-15. PubMed ID: 29173443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis.
    Salez F; Brichet A; Desurmont S; Grosbois JM; Wallaert B; Tonnel AB
    Chest; 1999 Dec; 116(6):1665-8. PubMed ID: 10593792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole.
    Denning DW; Van Wye JE; Lewiston NJ; Stevens DA
    Chest; 1991 Sep; 100(3):813-9. PubMed ID: 1653680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Life-threatening allergic bronchopulmonary aspergillosis in a well child with cystic fibrosis.
    Skowronski E; Fitzgerald DA
    Med J Aust; 2005 May; 182(9):482-3. PubMed ID: 15865595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Allergic bronchopulmonary aspergillosis in paediatric cystic fibrosis patients.
    de Almeida MB; Bussamra MH; Rodrigues JC
    Paediatr Respir Rev; 2006 Mar; 7(1):67-72. PubMed ID: 16473820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Francis NZ; Southern KW
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002204. PubMed ID: 36053129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aspergillosis and atopy in cystic fibrosis.
    Nelson LA; Callerame ML; Schwartz RH
    Am Rev Respir Dis; 1979 Oct; 120(4):863-73. PubMed ID: 507513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.
    Nové-Josserand R; Grard S; Auzou L; Reix P; Murris-Espin M; Brémont F; Mammar B; Mely L; Hubert D; Durieu I; Burgel PR
    Pediatr Pulmonol; 2017 Feb; 52(2):190-197. PubMed ID: 27717223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum Cytokine Changes in a Patient with Chronic Pulmonary Aspergillosis Overlapping with Allergic Bronchopulmonary Aspergillosis.
    Tsukamoto Y; Ito Y; Obase Y; Takazono T; Nakada N; Ashizawa N; Hirayama T; Takeda K; Ide S; Iwanaga N; Tashiro M; Hosogaya N; Fukahori S; Fukushima C; Yanagihara K; Izumikawa K; Mukae H
    Intern Med; 2024 Jun; 63(11):1659-1664. PubMed ID: 37899245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.
    Chishimba L; Niven RM; Cooley J; Denning DW
    J Asthma; 2012 May; 49(4):423-33. PubMed ID: 22380765
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allergic bronchopulmonary aspergillosis in cystic fibrosis.
    Hanley-Lopez J; Clement LT
    Curr Opin Pulm Med; 2000 Nov; 6(6):540-4. PubMed ID: 11100966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Azoles for allergic bronchopulmonary aspergillosis associated with asthma.
    Wark PA; Gibson PG; Wilson AJ
    Cochrane Database Syst Rev; 2003; (3):CD001108. PubMed ID: 12917898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful Treatment of Allergic Bronchopulmonary Aspergillosis Using a Combination of Inhaled Fluticasone Furoate/Vilanterol and Oral Voriconazole.
    Nishimatsu K; Minami S; Ikuta S; Ihara S; Komuta K
    J Med Cases; 2020 Nov; 11(11):348-351. PubMed ID: 34434345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
    Mroueh S; Spock A
    Chest; 1994 Jan; 105(1):32-6. PubMed ID: 8275769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.